Skip to main content
SpringerLink
Log in

Trials confirm benefits of carvedilol in post-MI and severe heart failure

  • Meeting report
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Rights and permissions

Reprints and permissions

About this article

Cite this article

Trials confirm benefits of carvedilol in post-MI and severe heart failure. Pharmacoecon. Outcomes News 314, 3–4 (2001). https://doi.org/10.1007/BF03280340

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03280340

Keywords

Search

Navigation